Systematic review with radiomics quality score of cholangiocarcinoma: an EuSoMII Radiomics Auditing Group Initiative

Abstract

Key points The quality of current radiomics studies on cholangiocarcinoma is insufficient, with a median radiomics quality score of 8–10, corresponding to 22–28% of the ideal quality score. None of the current studies conducted phantom assessment, imaging at multiple time points, prospective registration in a trial database, nor cost-effectiveness analysis. The inter-reader agreement of the radiomics quality score is good (ICC of 0.75; 95% CI 0.62–0.85) among readers with different levels of experience.

Keywords

• Systematic review
• Cholangiocarcinoma
• Liver
• Quality improvement